Neurocrine Biosciences Inc logo

Neurocrine Biosciences Inc

$ 122.15 +3.18 (+2.67%) 10:08 PM EST
On watch
P/E:
214.30
P/B:
7.60
Market Cap:
$ 11.74B
Enterprise V:
$ 11.21B
Volume:
283.68K
Avg Vol (2M):
871.25K
Also Trade In:
Volume:
283.68K
Market Cap $:
11.74B
PE Ratio:
214.30
Avg Vol (2-Month):
871.25K
Enterprise Value $:
11.21B
PB Ratio:
7.60
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.
Name Current Vs Industry Vs History
Cash-To-Debt 3.01
Equity-to-Asset 0.72
Debt-to-Equity 0.17
Debt-to-EBITDA 2.44
Interest Coverage 16.63
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 12.64
Distress
Grey
Safe
Beneish M-Score -1.93
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 63.41
9-Day RSI 59.33
14-Day RSI 58.6
6-1 Month Momentum % 27.39
12-1 Month Momentum % 28.15

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.49
Quick Ratio 2.41
Cash Ratio 1.65
Days Inventory 563.52
Days Sales Outstanding 62.71
Days Payable 959.06

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.5

Financials (Next Earnings Date:2023-02-10 Est.)

NBIX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NBIX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 1,388.7
EPS (TTM) ($) 0.57
Beta 0.36
Volatility % 32.16
14-Day RSI 58.6
14-Day ATR ($) 4.088144
20-Day SMA ($) 119.549
12-1 Month Momentum % 28.15
52-Week Range ($) 71.875 - 125.99
Shares Outstanding (Mil) 96.13

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Neurocrine Biosciences Inc Filings

Document Form Filing Date
No Filing Data

Neurocrine Biosciences Inc Analysis

Share your research

Headlines

See More
No news.